RecruitingEarly Phase 1NCT06520982

Early Neurovascular Adaptations in Aging Women


Sponsor

University of Missouri-Columbia

Enrollment

64 participants

Start Date

Sep 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Our goal is to enhance our understanding of early vascular adaptations in aging women with an emphasis on the sympathetic nervous system.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 70 Years

Inclusion Criteria2

  • Assigned female at birth (AFAB)
  • years of age

Exclusion Criteria12

  • Assigned male at birth (AMAB)
  • Pregnancy, breastfeeding
  • Body mass index ≥30 kg/m2
  • Taking medications known to affect metabolic, autonomic, and/or respiratory function
  • Oral hormonal contraception in last 6 month
  • History of hormone replacement therapy
  • History of hyster- or oophor-ectomy
  • Current smoking/Nicotine use
  • Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
  • Chronic disease
  • Blood pressure ≥140/90 mmHg
  • Communication barriers

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNorepinephrine

Infused intra-arterially in a dose-response fashion

DRUGIsoproterenol

Infused intra-arterially in a dose-response fashion

DRUGAcetylcholine

Infused intra-arterially in a dose-response fashion

DRUGNitroprusside

Infused intra-arterially in a dose-response fashion

DRUGEstrogen

Infused intra-arterially


Locations(1)

University of Missouri-Columbia

Columbia, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06520982


Related Trials